Currently holds a position at ACADIA Pharmaceuticals Inc
Position | Company | Period |
---|---|---|
President | ACADIA Pharmaceuticals Inc | Nov. 19, 2018 - |
Executive Vice President, Head - Research and Development | ACADIA Pharmaceuticals Inc | Nov. 30, 2015 - Nov. 19, 2018 |
Senior Vice President - Clinical Development | Alkermes Plc | Sept. 30, 2013 - March 31, 2014 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2022-11-22 | 2022-11-21 |
ACADIA Pharmaceuticals Inc
(ACAD)
|
S Sale |
1,847
-2.9%
15.0727,834 USD |
1,847 -2.9% | 15.07 | 27,834 USD | |
2022-10-18 | 2022-10-15 |
ACADIA Pharmaceuticals Inc
(ACAD)
|
S Sale |
1,326
-2.3%
15.8120,964 USD |
1,326 -2.3% | 15.81 | 20,964 USD | |
2022-05-03 | 2022-05-02 |
ACADIA Pharmaceuticals Inc
(ACAD)
|
S Sale |
2,865
-4.9%
18.1852,091 USD |
2,865 -4.9% | 18.18 | 52,091 USD | |
2022-02-25 | 2022-02-23 |
ACADIA Pharmaceuticals Inc
(ACAD)
|
S Sale |
1,501
-3.0%
23.8035,724 USD |
1,501 -3.0% | 23.80 | 35,724 USD | |
2022-01-10 | 2022-01-06 |
ACADIA Pharmaceuticals Inc
(ACAD)
|
S Sale |
1,937
-4.1%
23.0544,648 USD |
1,937 -4.1% | 23.05 | 44,648 USD | |
2021-11-23 | 2021-11-22 |
ACADIA Pharmaceuticals Inc
(ACAD)
|
S Sale |
2,803
-6.3%
19.0153,285 USD |
2,803 -6.3% | 19.01 | 53,285 USD | |
2021-10-19 | 2021-10-18 |
ACADIA Pharmaceuticals Inc
(ACAD)
|
S Sale |
1,338
-3.4%
17.4123,295 USD |
1,338 -3.4% | 17.41 | 23,295 USD | |
2021-04-30 | 2021-04-30 |
ACADIA Pharmaceuticals Inc
(ACAD)
|
S Sale |
4,230
-10.4%
20.3385,996 USD |
4,230 -10.4% | 20.33 | 85,996 USD | |
2021-02-08 | 2021-02-04 |
ACADIA Pharmaceuticals Inc
(ACAD)
|
S Sale |
8,429
-21.4%
50.61426,592 USD |
8,429 -21.4% | 50.61 | 426,592 USD | |
2021-01-14 | 2021-01-12 |
ACADIA Pharmaceuticals Inc
(ACAD)
|
PS Planned sale |
700
-3.3%
55.0138,507 USD |
700 -3.3% | 55.01 | 38,507 USD | |
2021-01-08 | 2021-01-08 |
ACADIA Pharmaceuticals Inc
(ACAD)
|
PS Planned sale |
29,733
-59.5%
55.221,641,832 USD |
29,733 -59.5% | 55.22 | 1,641,832 USD | |
2021-01-08 | 2021-01-07 |
ACADIA Pharmaceuticals Inc
(ACAD)
|
PS Planned sale |
61,619
-75.3%
55.123,396,187 USD |
61,619 -75.3% | 55.12 | 3,396,187 USD | |
2021-01-08 | 2021-01-06 |
ACADIA Pharmaceuticals Inc
(ACAD)
|
S Sale |
1,725
-7.9%
53.3492,012 USD |
1,725 -7.9% | 53.34 | 92,012 USD | |
2020-11-20 | 2020-11-20 |
ACADIA Pharmaceuticals Inc
(ACAD)
|
S Sale |
2,728
-14.2%
53.50145,948 USD |
2,728 -14.2% | 53.50 | 145,948 USD | |
2020-10-19 | 2020-10-16 |
ACADIA Pharmaceuticals Inc
(ACAD)
|
S Sale |
1,297
-9.1%
42.5655,200 USD |
1,297 -9.1% | 42.56 | 55,200 USD | |
2020-06-19 | 2020-06-19 |
ACADIA Pharmaceuticals Inc
(ACAD)
|
PS Planned sale |
16,452
-59.2%
50.12824,515 USD |
16,452 -59.2% | 50.12 | 824,515 USD | |
2020-06-19 | 2020-06-18 |
ACADIA Pharmaceuticals Inc
(ACAD)
|
PS Planned sale |
65,843
-85.3%
50.013,292,729 USD |
65,843 -85.3% | 50.01 | 3,292,729 USD | |
2020-05-01 | 2020-04-30 |
ACADIA Pharmaceuticals Inc
(ACAD)
|
S Sale |
4,308
-27.5%
49.21211,997 USD |
4,308 -27.5% | 49.21 | 211,997 USD | |
2020-04-24 | 2020-04-23 |
ACADIA Pharmaceuticals Inc
(ACAD)
|
PS Planned sale |
18,949
-75.9%
50.07948,729 USD |
18,949 -75.9% | 50.07 | 948,729 USD | |
2020-04-22 | 2020-04-22 |
ACADIA Pharmaceuticals Inc
(ACAD)
|
PS Planned sale |
54,019
-90.0%
50.022,701,906 USD |
54,019 -90.0% | 50.02 | 2,701,906 USD | |
2020-04-22 | 2020-04-20 |
ACADIA Pharmaceuticals Inc
(ACAD)
|
PS Planned sale |
100,000
-94.3%
50.155,015,450 USD |
100,000 -94.3% | 50.15 | 5,015,450 USD | |
2019-10-17 | 2019-10-15 |
ACADIA Pharmaceuticals Inc
(ACAD)
|
S Sale |
1,031
-34.7%
39.6540,879 USD |
1,031 -34.7% | 39.65 | 40,879 USD |